Dissemination communication and exploitation

Leading partner organisation: REGION HOVEDSTADEN/Centre of Excellence for Health, Immunity and Infections (CHIP) (Denmark)

The CARE network adopts a committed approach to dissemination of the research outcomes, conclusions and results in order to ensure improved treatment and care practices for TB, HIV and hepatitis, thus ultimately helping to make  health care systems more efficient and improve treatment outcomes.

In order to maximize project impact, it is a key priority for CARE partners to disseminate and communicate the novel approaches developed to health professionals in the HIV/TB/HCV fields, e.g. microbiologists and clinicians in clinical care of patients, and to their respective clinical societies in charge of clinical guideline development.

In particular, the partners will seek to disseminate evidence based recommendation to health care decision makers and other relevant governmental bodies in charge of prioritizing and optimizing care in eastern European settings faced with high case load of HIV/TB/HCV infection and limited health budgets.

Integral to the project’s dissemination and exploitation activities is engaging dialogue with patient organisations, particularly PLHIV and liver patients, in order to provide information on the project’s research activities and receive feedback on their potential to impact health policies and treatment guidelines in Russia and the Eastern Europe.

Heading 1

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 825673.

Subscribe to the CARE newsletter

Francesca Incardona